Merck Acquires Cidara Therapeutics in $9.2 Billion Transaction

Gibson Dunn has advised Merck. Cooley has advised Cidara Therapeutics. Merck has entered into a definitive agreement to acquire Cidara Therapeutics, Inc., a biotechnology company specializing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here